Exome Asset Management LLC Arvinas, Inc. Transaction History
Exome Asset Management LLC
- $112 Billion
- Q1 2025
A detailed history of Exome Asset Management LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Exome Asset Management LLC holds 195,295 shares of ARVN stock, worth $1.42 Million. This represents 1.22% of its overall portfolio holdings.
Number of Shares
195,295
Previous 218,700
10.7%
Holding current value
$1.42 Million
Previous $4.19 Billion
67.3%
% of portfolio
1.22%
Previous 3.15%
Shares
3 transactions
Others Institutions Holding ARVN
# of Institutions
245Shares Held
62.5MCall Options Held
2.65MPut Options Held
1.1M-
Vanguard Group Inc Valley Forge, PA8.36MShares$61 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$45.6 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.88MShares$28.3 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.83MShares$27.9 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$24.3 Million0.38% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $388M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...